Vinod Khetarpal
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
-
- Genetic Neurodegenerative Diseases 11
-
- Mitochondrial Function and Pathology 6
- Co-authors
- Ladislav Volicer (2 shared papers)Pai-Chang Sheen (1 shared paper)M Potmĕsil (3 shared papers)Mervyn Israel (3 shared papers)Mark Levin (3 shared papers)Robert Silber (3 shared papers)Anna Goldfeder (1 shared paper)Ignacio Muñoz-Sanjuán (10 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Journal of Nuclear Medicine (2 papers)eLife (2 papers)Molecular Pharmaceutics (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Vinod Khetarpal
23 papers receiving 324 citations
Peers
Comparison fields: 5 of 71
- Pharmaceutical Science 69
- Biological Psychiatry 12
- Toxicology 16
- Neurology 34
- Behavioral Neuroscience 11
Countries citing papers authored by Vinod Khetarpal
This map shows the geographic impact of Vinod Khetarpal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod Khetarpal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod Khetarpal more than expected).
Fields of papers citing papers by Vinod Khetarpal
This network shows the impact of papers produced by Vinod Khetarpal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod Khetarpal. The network helps show where Vinod Khetarpal may publish in the future.
Co-authors
The 25 scholars most cited alongside Vinod Khetarpal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 77 | |
| 2 | Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. | 1981 | 51 |
| 3 | Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells. | 1983 | 42 |
| 4 | 1981 | 30 | |
| 5 | 2020 | 29 | |
| 6 | 2019 | 24 | |
| 7 | 2022 | 17 | |
| 8 | 2021 | 13 | |
| 9 | 2019 | 12 | |
| 10 | 1979 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 1983 | 7 | |
| 14 | 2024 | 4 | |
| 15 | 1994 | 3 | |
| 16 | 1975 | 3 | |
| 17 | 1995 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Vinod Khetarpal
Vinod Khetarpal is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Oncology, Neurology and Biological Psychiatry, having authored 27 papers that have together received 352 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (11 papers), Mitochondrial Function and Pathology (6 papers), Cancer Treatment and Pharmacology (4 papers), Neurological disorders and treatments (4 papers), Tryptophan and brain disorders (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Bipolar Disorder and Treatment (2 papers). The work is most often cited by research in Pharmaceutical Science (69 citations), Biological Psychiatry (12 citations), Toxicology (16 citations), Neurology (34 citations) and Behavioral Neuroscience (11 citations). Vinod Khetarpal has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Ladislav Volicer, Pai-Chang Sheen, M Potmĕsil, Mervyn Israel, Mark Levin, Robert Silber, Anna Goldfeder, Ignacio Muñoz-Sanjuán, S Kirschenbaum and Celia Dominguez. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, eLife, Molecular Pharmaceutics and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.